Heterogeneous nuclear ribonucleoprotein A1 pseudogene 2 (HNRNPA1P2)

HNRNPA1P2 is a processed pseudogene, which means it originates from the reverse transcription of mature mRNA of the parental gene HNRNPA1 and insertion back into the genome[4][6]. It contains sequence homology with the functional HNRNPA1 gene but carries mutations or deletions that prevent it from producing a functional protein[4][5][6]. Pseudogenes such as HNRNPA1P2 are generally considered non-coding, although recent research indicates that some pseudogenes may have *regulatory functions* at the RNA level, potentially influencing expression of their parent genes or participating in competing endogenous RNA (ceRNA) networks[3]. To date, there is no evidence that HNRNPA1P2 functions as a receptor, enzyme, transporter, or transcription factor, nor is it a current therapeutic target. Its main classification is as a **pseudogene**—a genomic sequence related to a known gene, but biologically inactive as a protein-coding gene[4][5][6]. There are no approved drugs targeting HNRNPA1P2, and its potential roles, if any, are most likely limited to gene regulation via RNA-based mechanisms[3].

Other names

dJ372B18.1HNRPA1P2GC06P032400GC06Pm32370